PATENTS
Over 100 patents give Momenta a strong proprietary position
Momenta possesses a strong intellectual property position around our characterization platform. We license or own a total of over 100 patents and patent applications. Our patent portfolio includes claims covering:
- methods and technologies for characterizing sugars;
- the use of certain enzymes and reagents that specifically recognize polysaccharides in the characterization of sugars;
- methods and technologies for chemical and metabolic synthesis of sugars;
- the composition of matter of certain novel low-molecular-weight herapins (LMWHs), including M118, and heparinase variants;
- methods to produce and identify sugars associated with glycoproteins;
- methods to analyze and monitor glycoprotein profiles for purposes associated with the diagnosis, staging, prognosis and monitoring of cancer; and
- methods for the in vivo non-invasive delivery of sugars.
We also rely on trade secrets, know-how, continuing technological innovation and in-licensing opportunities to develop and maintain our proprietary position.